CRM Publications

Barakat TStefan, Loos F, van Staveren S, Myronova E, Ghazvini M, J Grootegoed A, Gribnau J.  2014.  The trans-activator RNF12 and cis-acting elements effectuate X chromosome inactivation independent of X-pairing.Mol Cell. 53(6):965-78.

Gontan C, Achame EMulugeta, Demmers J, Barakat TStefan, Rentmeester E, van IJcken W, J Grootegoed A, Gribnau J.  2012.  RNF12 initiates X-chromosome inactivation by targeting REX1 for degradation.Nature. 485(7398):386-90.

Barakat TStefan, Gribnau J.  2012.  X chromosome inactivation in the cycle of life.Development. 139(12):2085-9.

Barakat TStefan, Jonkers I, Monkhorst K, Gribnau J.  2010.  X-changing information on X inactivation.Exp Cell Res. 316(5):679-87.

Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O, Wray J, Yamanaka S, Chambers I, Smith A.  2009.  Nanog is the gateway to the pluripotent ground state.Cell. 138(4):722-37.

Navarro P, Chambers I, Karwacki-Neisius V, Chureau C, Morey C, Rougeulle C, Avner P.  2008.  Molecular coupling of Xist regulation and pluripotency.Science. 321(5896):1693-5.

Morris L, Gordon J, C Blackburn C.  2006.  Identification of a tandem duplicated array in the Rhox alpha locus on mouse chromosome X.Mamm Genome. 17(2):178-87.

Kunath T, Arnaud D, Uy GD, Okamoto I, Chureau C, Yamanaka Y, Heard E, Gardner RL, Avner P, Rossant J.  2005.  Imprinted X-inactivation in extra-embryonic endoderm cell lines from mouse blastocysts.Development. 132(7):1649-61.

Caballero IMartín, Hendrich B.  2005.  MeCP2 in neurons: closing in on the causes of Rett syndrome.Hum Mol Genet. 14 Spec No 1:R19-26.

Peters AHFM, Mermoud JE, O'Carroll D, Pagani M, Schweizer D, Brockdorff N, Jenuwein T.  2002.  Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin.Nat Genet. 30(1):77-80.

Tate P, Skarnes W, Bird A.  1996.  The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse.Nat Genet. 12(2):205-8.